Hiroshi Nagasaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Nagasaka has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Tsutomu Mieda
6 shared publicationsHiroshi Hoshijima
5 shared publicationsTina Nakamura
5 shared publications- Hiroshi Hoshijima
Department of Anesthesiology, Saitama Medical University Hospital, 38 Morohongo, Moroyamacho Irumagun, Saitama 350-0495, Japan
4 shared publications Katsushi Doi
Department of Anesthesiology, Saitama Medical University Hospital, Saitama, Japan
3 shared publications- Tsutomu Mieda
Department of Anesthesiology, Saitama Medical University Hospital, 38 Morohongo, Moroyamacho Irumagun, Saitama 350-0495, Japan
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by AME Publishing Company in Journal of Oral and Maxillofacial Anesthesia
- Vol. 5  (1) , 25
Postoperative nausea and vomiting and pain after minor oral and maxillofacial surgery: clinical implications of a new associationâa response
Postoperative nausea and vomiting and pain after minor oral and maxillofacial surgery: clinical implications of a new associationâa response
- 1 September 2026
- Published by AME Publishing Company in Journal of Oral and Maxillofacial Anesthesia
- Vol. 5  (1) , 25
Open AccessPostoperative nausea and vomiting and pain after minor oral and maxillofacial surgery: clinical implications of a new associationâa response
Postoperative nausea and vomiting and pain after minor oral and maxillofacial surgery: clinical implications of a new associationâa response
- Open Access
- 29 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15  (17) , 6714
Association Between Postoperative Nausea Severity and Pain Intensity in Patients Experiencing Postoperative Nausea and Vomiting After Minor Oral and Maxillofacial Surgery: A Retrospective Cohort Study
Background: The relationship between postoperative nausea and vomiting (PONV) and postoperative pain (POP) has not yet been fully clarified. This investigation aimed to evaluate the association between postoperative nausea severity and the intensity of POP following minor oral and maxillofacial surgery (OMS) under general anesthesia. Methods: This retrospective cohort study reviewed data from patients aged 16 to 70 years who received general anesthesia with nasal intubation for minor OMS at our institution from January 2021 to August 2022; patients with pre-existing conditions influencing POP or PONV were excluded from the analysis. Predictor variables included nausea scores assessed with a 100 mm visual analog scale (VAS), with a secondary sub-analysis excluding asymptomatic patients. The primary and secondary outcomes were VAS-rated POP levels at early (2 h) and late and delayed (6 h and 24 h) time points post-surgery, respectively. Covariates encompassing patient demographics, anesthetic details, and surgical factors were adjusted for, with statistical significance defined as p < 0.05. Results: Out of the 160 patients analyzed, the PONV incidence rates were 20.0% (n = 32) at 0â2 h, 4.4% (n = 7) at 2â6 h, and 0% (n = 0) at 6â24 h. The results from the adjusted multivariate model analysis show that, in this cohort of 160 patientsâregardless of the presence or absence of PONVâhigher nausea severity was not significantly associated with a reduction in POP intensity at the 2 h mark in the primary analysis. However, in an exploratory subgroup analysis, in the 32 patients who experienced PONV at the 2 h time point, higher nausea severity was significantly associated with lower POP levels [regression coefficient = â0.45, 95% confidence interval = â0.77 to â0.14, p = 0.006]. Conclusions: These results demonstrate an inverse statistical association between nausea severity and POP intensity at 2 h within a small subgroup of 32 patients with PONV. However, these findings do not establish a causal relationship.
- 29 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15  (17) , 6714
Open AccessAssociation Between Postoperative Nausea Severity and Pain Intensity in Patients Experiencing Postoperative Nausea and Vomiting After Minor Oral and Maxillofacial Surgery: A Retrospective Cohort Study
Background: The relationship between postoperative nausea and vomiting (PONV) and postoperative pain (POP) has not yet been fully clarified. This investigation aimed to evaluate the association between postoperative nausea severity and the intensity of POP following minor oral and maxillofacial surgery (OMS) under general anesthesia. Methods: This retrospective cohort study reviewed data from patients aged 16 to 70 years who received general anesthesia with nasal intubation for minor OMS at our institution from January 2021 to August 2022; patients with pre-existing conditions influencing POP or PONV were excluded from the analysis. Predictor variables included nausea scores assessed with a 100 mm visual analog scale (VAS), with a secondary sub-analysis excluding asymptomatic patients. The primary and secondary outcomes were VAS-rated POP levels at early (2 h) and late and delayed (6 h and 24 h) time points post-surgery, respectively. Covariates encompassing patient demographics, anesthetic details, and surgical factors were adjusted for, with statistical significance defined as p < 0.05. Results: Out of the 160 patients analyzed, the PONV incidence rates were 20.0% (n = 32) at 0â2 h, 4.4% (n = 7) at 2â6 h, and 0% (n = 0) at 6â24 h. The results from the adjusted multivariate model analysis show that, in this cohort of 160 patientsâregardless of the presence or absence of PONVâhigher nausea severity was not significantly associated with a reduction in POP intensity at the 2 h mark in the primary analysis. However, in an exploratory subgroup analysis, in the 32 patients who experienced PONV at the 2 h time point, higher nausea severity was significantly associated with lower POP levels [regression coefficient = â0.45, 95% confidence interval = â0.77 to â0.14, p = 0.006]. Conclusions: These results demonstrate an inverse statistical association between nausea severity and POP intensity at 2 h within a small subgroup of 32 patients with PONV. However, these findings do not establish a causal relationship.
- Open Access
Incidence of Clinically Documented Phantom Limb Pain During Hospitalization and Preoperative Risk Factors in Patients Who Underwent Nontraumatic Major Lower Limb Amputation: A Single-Center, Retrospective Study
Background and Objectives: Phantom limb pain (PLP) frequently occurs after lower limb amputation (LLA). However, a consensus has not been reached regarding its incidence, particularly in nontraumatic amputations, because reported estimates vary according to case mix, follow-up duration, and outcome definitions. Data from Japan remain limited. Methods: After approval by the Institutional Review Board, the electronic medical records of patients who underwent above-knee amputation (AKA) or below-knee amputation (BKA) at Saitama Medical University Hospital between 1 January 2012 and 31 December 2024 were retrospectively reviewed. The primary outcome was the incidence of clinically documented PLP during hospitalization, typically within approximately 1â2 months after amputation. PLP was defined as a painful sensation in the amputated limb documented in the medical record and diagnosed by surgeons or anesthesiologists. Postamputation pain due to symptomatic neuroma was not classified as PLP. Patients with only nonpainful phantom limb sensations were not considered to have the primary outcome. Patients aged 18 years or older who required nontraumatic AKA or BKA were included. Patients who (1) died within 30 days of surgery or (2) were unable to communicate were excluded. Results: Clinically documented PLP occurred in 31 of 298 patients (10.4%; exact 95% CI, 7.2â14.4%) during hospitalization. In the prespecified primary model including age and preoperative pain, younger age (adjusted odds ratio (OR) 0.96 per 1-year increase, 95% confidence interval (CI) 0.93â0.99; p = 0.008) and preoperative pain (adjusted OR 16.34, 95% CI 3.75â71.24; p < 0.001) were associated with PLP. In an exploratory model additionally including postoperative pain on the day of surgery, postoperative pain was not independently associated with PLP. Firth penalized logistic regression yielded similar results. Conclusions: This study found a 10.4% incidence of clinically documented PLP during hospitalization after nontraumatic major LLA. Younger age and preoperative pain were associated with PLP, although the estimates should be interpreted cautiously because only 31 PLP events occurred.
Open AccessIncidence of Clinically Documented Phantom Limb Pain During Hospitalization and Preoperative Risk Factors in Patients Who Underwent Nontraumatic Major Lower Limb Amputation: A Single-Center, Retrospective Study
Background and Objectives: Phantom limb pain (PLP) frequently occurs after lower limb amputation (LLA). However, a consensus has not been reached regarding its incidence, particularly in nontraumatic amputations, because reported estimates vary according to case mix, follow-up duration, and outcome definitions. Data from Japan remain limited. Methods: After approval by the Institutional Review Board, the electronic medical records of patients who underwent above-knee amputation (AKA) or below-knee amputation (BKA) at Saitama Medical University Hospital between 1 January 2012 and 31 December 2024 were retrospectively reviewed. The primary outcome was the incidence of clinically documented PLP during hospitalization, typically within approximately 1â2 months after amputation. PLP was defined as a painful sensation in the amputated limb documented in the medical record and diagnosed by surgeons or anesthesiologists. Postamputation pain due to symptomatic neuroma was not classified as PLP. Patients with only nonpainful phantom limb sensations were not considered to have the primary outcome. Patients aged 18 years or older who required nontraumatic AKA or BKA were included. Patients who (1) died within 30 days of surgery or (2) were unable to communicate were excluded. Results: Clinically documented PLP occurred in 31 of 298 patients (10.4%; exact 95% CI, 7.2â14.4%) during hospitalization. In the prespecified primary model including age and preoperative pain, younger age (adjusted odds ratio (OR) 0.96 per 1-year increase, 95% confidence interval (CI) 0.93â0.99; p = 0.008) and preoperative pain (adjusted OR 16.34, 95% CI 3.75â71.24; p < 0.001) were associated with PLP. In an exploratory model additionally including postoperative pain on the day of surgery, postoperative pain was not independently associated with PLP. Firth penalized logistic regression yielded similar results. Conclusions: This study found a 10.4% incidence of clinically documented PLP during hospitalization after nontraumatic major LLA. Younger age and preoperative pain were associated with PLP, although the estimates should be interpreted cautiously because only 31 PLP events occurred.
- 30 November 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83  (3) , 279-285
Is Postoperative Nausea and Vomiting Associated With Increased Postoperative Pain in Patients Undergoing Minor Oral and Maxillofacial Surgery Under General Anesthesia?
- 30 November 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 83  (3) , 279-285
Is Postoperative Nausea and Vomiting Associated With Increased Postoperative Pain in Patients Undergoing Minor Oral and Maxillofacial Surgery Under General Anesthesia?
- Open Access
- 7 October 2024
- Published by Springer Nature in JA Clinical Reports
- Vol. 10  (1) , 1-4
Intracranial epidural hematoma after spinal anesthesia for cesarean section: a case report
Background: Although subdural hematoma is a rare complication after spinal anesthesia, there have been no reports of an intracranial epidural hematoma after cesarean section with spinal anesthesia. Case presentation: A 32-year-old nulliparous woman at the 35th week of a twin pregnancy underwent an emergency cesarean section due to her first contraction. She had no preoperative complications and the spinal anesthesia was uneventful, with 0.5% bupivacaine 12 mg and fentanyl 15 µg from the L3/4 intervertebral space. She complained of headache and nausea 15 min after spinal anesthesia, demonstrating a consciousness disturbance after surgery. Computed tomography 2 h after the cesarean section revealed an intracranial epidural hematoma. She underwent decompressive craniotomy 1 h later. Conclusion: This case highlights the possible development of an intracranial epidural hematoma in low-risk obstetric patients.
- 7 October 2024
- Published by Springer Nature in JA Clinical Reports
- Vol. 10  (1) , 1-4
Open AccessIntracranial epidural hematoma after spinal anesthesia for cesarean section: a case report
Background: Although subdural hematoma is a rare complication after spinal anesthesia, there have been no reports of an intracranial epidural hematoma after cesarean section with spinal anesthesia. Case presentation: A 32-year-old nulliparous woman at the 35th week of a twin pregnancy underwent an emergency cesarean section due to her first contraction. She had no preoperative complications and the spinal anesthesia was uneventful, with 0.5% bupivacaine 12 mg and fentanyl 15 µg from the L3/4 intervertebral space. She complained of headache and nausea 15 min after spinal anesthesia, demonstrating a consciousness disturbance after surgery. Computed tomography 2 h after the cesarean section revealed an intracranial epidural hematoma. She underwent decompressive craniotomy 1 h later. Conclusion: This case highlights the possible development of an intracranial epidural hematoma in low-risk obstetric patients.
- Open Access
- 22 February 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102  (8) , e33047
Hemodynamic response related to the Airway Scope versus the Macintosh laryngoscope: A systematic review and meta-analysis with trial sequential analysis
Background: It is important to reduce the hemodynamic response during tracheal intubation. We performed a systematic review and meta-analysis of the Airway Scope and Macintosh laryngoscope to determine whether they reduce the hemodynamic responses of heart rate (HR) and mean blood pressure (MBP) after tracheal intubation under general anesthesia. Methods: We performed a comprehensive literature search of electronic databases for clinical trials comparing hemodynamic response to tracheal intubation. The primary aim of our meta-analyst is to determine if the Airway Scope reduces hemodynamic responses (HR and mean MBP) 60 seconds after tracheal intubation compared to the Macintosh laryngoscope. We expressed pooled differences in hemodynamic responses between the 2 devices as weighted mean differences with 95% confidence intervals. We conducted trial sequential analysis. Secondarily, we investigated the ability of the Airway Scope and Macintosh laryngoscope to reduce hemodynamic responses at 120 seconds, 180 seconds, and 300 seconds after tracheal intubation. Results: We identified clinical trials comparing hemodynamic response via a comprehensive literature search. Of 185 articles found in the search, we selected 8. In comparison to the Macintosh laryngoscope, the Airway Scope significantly reduced HR and MBP at 60 seconds after tracheal intubation (HR; weighted mean difference = â7.29; 95% confidence interval, â10.9 to â3.62; P < .0001; I 2 = 57%, MBP; weighted mean difference = â11.5; 95% confidence interval, â20.4 to â2.65; P = .01; I 2 = 91%). At the secondary outcome, the Airway Scope significantly reduced the fluctuation of HR after 120 seconds and 180 seconds of tracheal intubation. However, the Airway Scope did not significantly reduce MBP 120 seconds, 180 seconds, and 300 seconds after tracheal intubation. Trial sequential analysis suggested that the total sample size reached the required information size for heart rate. Conclusions: Our finding suggested that the Airway Scope attenuated hemodynamic responses at 60 seconds after tracheal intubation in comparison with that of the Macintosh laryngoscope. However, the MBP sample size is small and further research is needed.
- 22 February 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102  (8) , e33047
Open AccessHemodynamic response related to the Airway Scope versus the Macintosh laryngoscope: A systematic review and meta-analysis with trial sequential analysis
Background: It is important to reduce the hemodynamic response during tracheal intubation. We performed a systematic review and meta-analysis of the Airway Scope and Macintosh laryngoscope to determine whether they reduce the hemodynamic responses of heart rate (HR) and mean blood pressure (MBP) after tracheal intubation under general anesthesia. Methods: We performed a comprehensive literature search of electronic databases for clinical trials comparing hemodynamic response to tracheal intubation. The primary aim of our meta-analyst is to determine if the Airway Scope reduces hemodynamic responses (HR and mean MBP) 60 seconds after tracheal intubation compared to the Macintosh laryngoscope. We expressed pooled differences in hemodynamic responses between the 2 devices as weighted mean differences with 95% confidence intervals. We conducted trial sequential analysis. Secondarily, we investigated the ability of the Airway Scope and Macintosh laryngoscope to reduce hemodynamic responses at 120 seconds, 180 seconds, and 300 seconds after tracheal intubation. Results: We identified clinical trials comparing hemodynamic response via a comprehensive literature search. Of 185 articles found in the search, we selected 8. In comparison to the Macintosh laryngoscope, the Airway Scope significantly reduced HR and MBP at 60 seconds after tracheal intubation (HR; weighted mean difference = â7.29; 95% confidence interval, â10.9 to â3.62; P < .0001; I 2 = 57%, MBP; weighted mean difference = â11.5; 95% confidence interval, â20.4 to â2.65; P = .01; I 2 = 91%). At the secondary outcome, the Airway Scope significantly reduced the fluctuation of HR after 120 seconds and 180 seconds of tracheal intubation. However, the Airway Scope did not significantly reduce MBP 120 seconds, 180 seconds, and 300 seconds after tracheal intubation. Trial sequential analysis suggested that the total sample size reached the required information size for heart rate. Conclusions: Our finding suggested that the Airway Scope attenuated hemodynamic responses at 60 seconds after tracheal intubation in comparison with that of the Macintosh laryngoscope. However, the MBP sample size is small and further research is needed.
- Open Access
- 23 December 2022
- Published by Springer Nature in Lasers in Medical Science
- Vol. 38  (1) , 1-11
Photobiomodulation enhanced endogenous pain modulation in healthy volunteers
To examine the effects of photobiomodulation (PBM) in healthy volunteers using photonic stimulation of acupuncture points on conditioned pain modulation (CPM), temporal summation of pain (TSP), and offset analgesia (OA), which reflect some aspects of endogenous pain modulation. We included 15 men and 15 women (age, 31.5 [27.3â37.0], body mass index, 25.7 [24.4â27.1], Fitzpatrick skin typing, II: 20, III: 8, IV: 2). CPM, TSP, and OA were evaluated after a sham procedure (control session) and after acupuncture point stimulation (LI4 and LI10 on the non-dominant forearm) using linear polarized near-infrared light irradiation (LPNILI; wavelengths peaked at approximately 1000 nm, output: 1.4 W/cm2, spot diameter: 10 mm, spot size: 1.02 cm2, maximum temperature: 40.5 °C, pulse width: 1 s, frequency: 0.2 Hz) (PBM session). Differences in CPM, TSP, and OA between the two sessions were evaluated by the paired t-test and Fisherâs exact test (statistical significance: p < 0.05). Values indicate median [interquartile range]. LPNILI significantly increased CPM in all participants (control session: 12.1 [â4.5â37.4], PBM session: 23.9 [8.3â44.8], p < 0.05) and women (control session: 16.7 [â3.4â36.6], PBM session: 38.7 [24.6â52.1], p < 0.05). The CPM effect increment was significantly higher in women than in men (p = 0.0253). LPNILI decreased TSP in participants with higher TSP ratios (p = 0.0219) and increased OA in participants with lower OA scores (p = 0.0021). LPNILI enhanced endogenous pain modulation in healthy volunteers, particularly in women, as evaluated using CPM. CPM, TSP, and OA evaluations are potentially useful for discriminating PBM responders from non-responders.
- 23 December 2022
- Published by Springer Nature in Lasers in Medical Science
- Vol. 38  (1) , 1-11
Open AccessPhotobiomodulation enhanced endogenous pain modulation in healthy volunteers
To examine the effects of photobiomodulation (PBM) in healthy volunteers using photonic stimulation of acupuncture points on conditioned pain modulation (CPM), temporal summation of pain (TSP), and offset analgesia (OA), which reflect some aspects of endogenous pain modulation. We included 15 men and 15 women (age, 31.5 [27.3â37.0], body mass index, 25.7 [24.4â27.1], Fitzpatrick skin typing, II: 20, III: 8, IV: 2). CPM, TSP, and OA were evaluated after a sham procedure (control session) and after acupuncture point stimulation (LI4 and LI10 on the non-dominant forearm) using linear polarized near-infrared light irradiation (LPNILI; wavelengths peaked at approximately 1000 nm, output: 1.4 W/cm2, spot diameter: 10 mm, spot size: 1.02 cm2, maximum temperature: 40.5 °C, pulse width: 1 s, frequency: 0.2 Hz) (PBM session). Differences in CPM, TSP, and OA between the two sessions were evaluated by the paired t-test and Fisherâs exact test (statistical significance: p < 0.05). Values indicate median [interquartile range]. LPNILI significantly increased CPM in all participants (control session: 12.1 [â4.5â37.4], PBM session: 23.9 [8.3â44.8], p < 0.05) and women (control session: 16.7 [â3.4â36.6], PBM session: 38.7 [24.6â52.1], p < 0.05). The CPM effect increment was significantly higher in women than in men (p = 0.0253). LPNILI decreased TSP in participants with higher TSP ratios (p = 0.0219) and increased OA in participants with lower OA scores (p = 0.0021). LPNILI enhanced endogenous pain modulation in healthy volunteers, particularly in women, as evaluated using CPM. CPM, TSP, and OA evaluations are potentially useful for discriminating PBM responders from non-responders.
- Open Access
- 10 March 2022
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 54  (1) , 94-96
Postoperative recurrence of paralysis following extravascular injection of rocuronium bromide in an elderly patient with normal renal and hepatic function
- 10 March 2022
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 54  (1) , 94-96
Open AccessPostoperative recurrence of paralysis following extravascular injection of rocuronium bromide in an elderly patient with normal renal and hepatic function
- Open Access
- 10 December 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100  (49) , e28209
Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy
Rationale: With Duchenne muscular dystrophy (DMD) being the most common and most severe type of muscular dystrophy, DMD patients are at risk for complications from general anesthesia due to impaired cardiac and respiratory functions as the pathological condition progresses. In recent years, advances in multidisciplinary treatment have improved the prognosis of DMD patients, and the number of patients requiring surgery has increased. Remimazolam is a benzodiazepine derivative similar to midazolam. Its circulatory stability and the fact that it has an antagonist make it superior to propofol. There are no reports of pediatric patients with DMD undergoing total intravenous anesthesia with remimazolam. Patient concerns: A 4-year boy was scheduled for single-incision laparoscopic percutaneous extraperitoneal closure for inguinal hernia under general anesthesia, but the surgery was postponed because his serum creatine phosphokinase level was extremely high. Diagnosis: He was diagnosed with DMD. According to the results of the genetic test, exon deletion of the DMD gene was detected using multiplex ligation-dependent probe amplification, although he had no symptoms of DMD except for elevated serum levels of creatine phosphokinase, etc. Intervention: He was admitted for the same surgical purpose. Anesthesia was induced with 3 mg of intravenously administered remimazolam. He lost the ability to respond to verbal commands. After the intravenous administration of 100 ÎŒg of fentanyl, a continuous infusion of remifentanil (1.0 ÎŒg/kg/min) and remimazolam (15 mg/h) was started, and the endotracheal tube was inserted smoothly after the administration of 10 mg of rocuronium with which the muscle twitches disappeared in train-of-four monitoring. At the end of the surgery, 15 mg of flurbiprofen was administered intravenously. After surgery, we injected 40 mg of sugammadex to confirm a train-of-four count of 100%. Outcomes: Although the dose of remimazolam was reduced to 5 mg/h 30 minutes before the end of the surgery, it took 20 minutes after the discontinuation of remimazolam for the patient to open his eyes upon verbal command. On postoperative Day 2, he was discharged from the hospital without any complications. Lessons: Remimazolam was shown to be safe to use for general anesthesia in a pediatric patient with DMD.
- 10 December 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100  (49) , e28209
Open AccessAnesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy
Rationale: With Duchenne muscular dystrophy (DMD) being the most common and most severe type of muscular dystrophy, DMD patients are at risk for complications from general anesthesia due to impaired cardiac and respiratory functions as the pathological condition progresses. In recent years, advances in multidisciplinary treatment have improved the prognosis of DMD patients, and the number of patients requiring surgery has increased. Remimazolam is a benzodiazepine derivative similar to midazolam. Its circulatory stability and the fact that it has an antagonist make it superior to propofol. There are no reports of pediatric patients with DMD undergoing total intravenous anesthesia with remimazolam. Patient concerns: A 4-year boy was scheduled for single-incision laparoscopic percutaneous extraperitoneal closure for inguinal hernia under general anesthesia, but the surgery was postponed because his serum creatine phosphokinase level was extremely high. Diagnosis: He was diagnosed with DMD. According to the results of the genetic test, exon deletion of the DMD gene was detected using multiplex ligation-dependent probe amplification, although he had no symptoms of DMD except for elevated serum levels of creatine phosphokinase, etc. Intervention: He was admitted for the same surgical purpose. Anesthesia was induced with 3 mg of intravenously administered remimazolam. He lost the ability to respond to verbal commands. After the intravenous administration of 100 ÎŒg of fentanyl, a continuous infusion of remifentanil (1.0 ÎŒg/kg/min) and remimazolam (15 mg/h) was started, and the endotracheal tube was inserted smoothly after the administration of 10 mg of rocuronium with which the muscle twitches disappeared in train-of-four monitoring. At the end of the surgery, 15 mg of flurbiprofen was administered intravenously. After surgery, we injected 40 mg of sugammadex to confirm a train-of-four count of 100%. Outcomes: Although the dose of remimazolam was reduced to 5 mg/h 30 minutes before the end of the surgery, it took 20 minutes after the discontinuation of remimazolam for the patient to open his eyes upon verbal command. On postoperative Day 2, he was discharged from the hospital without any complications. Lessons: Remimazolam was shown to be safe to use for general anesthesia in a pediatric patient with DMD.
- 1 July 2020
- Published by Wiley in Anaesthesia Reports
- Vol. 8  (2) , 98-100
Rocuronium priming for tracheal intubation in COVIDâ19 patients
Summary: Priming doses of nonâdepolarising neuromuscular blocking drugs given before administration of anaesthetic agents have been used to hasten the onset of neuromuscular blockade. In the settings of coronavirus disease 2019 (COVIDâ19), this could be used to reduce the apnoeic, and potentially aerosolâgenerating, window. To our knowledge, we report the first cases of tracheal intubation with rocuronium for COVIDâ19 using the priming principle. Both patients needed their tracheas intubated for severe hypoxia using a rapid sequence induction technique with a priming dose of rocuronium. Despite adequate preâoxygenation a sudden, unexpected fall in arterial oxygen saturations was observed in both patients after administration of a priming dose of 2 mg of rocuronium. Clinicians should consider this possible risk associated with priming doses of neuromuscular blocking drugs in the management of patients with respiratory failure due to COVIDâ19.
- 1 July 2020
- Published by Wiley in Anaesthesia Reports
- Vol. 8  (2) , 98-100
Rocuronium priming for tracheal intubation in COVIDâ19 patients
Summary: Priming doses of nonâdepolarising neuromuscular blocking drugs given before administration of anaesthetic agents have been used to hasten the onset of neuromuscular blockade. In the settings of coronavirus disease 2019 (COVIDâ19), this could be used to reduce the apnoeic, and potentially aerosolâgenerating, window. To our knowledge, we report the first cases of tracheal intubation with rocuronium for COVIDâ19 using the priming principle. Both patients needed their tracheas intubated for severe hypoxia using a rapid sequence induction technique with a priming dose of rocuronium. Despite adequate preâoxygenation a sudden, unexpected fall in arterial oxygen saturations was observed in both patients after administration of a priming dose of 2 mg of rocuronium. Clinicians should consider this possible risk associated with priming doses of neuromuscular blocking drugs in the management of patients with respiratory failure due to COVIDâ19.